» Articles » PMID: 16580581

Metabolic Risk Factors and Markers of Cardiovascular and Renal Damage in Overweight Subjects

Overview
Journal Am J Hypertens
Date 2006 Apr 4
PMID 16580581
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prevalence of overweight and obesity in the United States has dramatically increased. Obesity clusters with a variety of hemodynamic and metabolic disturbances that increase the risk of cardiovascular disease. In this study we evaluated whether overweight subjects with hypertension also manifest hemodynamic and metabolic abnormalities compared with individuals of normal weight.

Methods: In a cohort of 129 patients with essential hypertension we measured the relationship between body mass index (BMI), blood pressure (BP), insulin sensitivity, lipid profile, and markers of organ damage including thickness of the carotid artery (IMT) and urine albumin excretion (UAE). A total of 41 normotensive, age-matched, healthy individuals served as control subjects.

Results: Hypertensive individuals showed higher levels of serum triglycerides, insulin area-under-the-curve (AUC), UAE, and greater IMT than normotensive subjects. Overweight hypertensive subjects showed higher levels of serum triglycerides, LDL cholesterol, glucose AUC, insulin AUC, UAE, and IMT than hypertensive subjects with normal body weight (BMI <25). Night-time systolic BP was higher and night-time fall in BP was lower among overweight than among normal-weight hypertensive patients. Simple regression analysis showed that BMI was correlated with age, UAE, BP, insulin and glucose AUC, serum triglycerides, cholesterol, and IMT in hypertensive subjects. However multiple regression analyses showed that BMI significantly correlated only with UAE.

Conclusions: The study results show that increased body weight clusters with a variety of hemodynamic and metabolic abnormalities in hypertensive subjects. However multiple regression analyses showed a significant correlation only between BMI and UAE, a marker and predictor of cardiovascular and renal disease.

Citing Articles

Elevated Circulating PCSK9 Concentrations Predict Subclinical Atherosclerotic Changes in Low Risk Obese and Non-Obese Patients.

Toth S, Fedacko J, Pekarova T, Hertelyova Z, Katz M, Mughees A Cardiol Ther. 2017; 6(2):281-289.

PMID: 28623549 PMC: 5688969. DOI: 10.1007/s40119-017-0092-8.


Association between carotid intima-media thickness and index of central fat distribution in middle-aged and elderly Chinese.

Ren C, Zhang J, Xu Y, Xu B, Sun W, Sun J Cardiovasc Diabetol. 2014; 13:139.

PMID: 25359238 PMC: 4219037. DOI: 10.1186/s12933-014-0139-2.


Reduced ENaC activity and blood pressure in mice with genetic knockout of the insulin receptor in the renal collecting duct.

Li L, Garikepati R, Tsukerman S, Kohan D, Wade J, Tiwari S Am J Physiol Renal Physiol. 2012; 304(3):F279-88.

PMID: 23195676 PMC: 3566522. DOI: 10.1152/ajprenal.00161.2012.


Cross-sectional epidemiological study to evaluate the cardiovascular profile of a cohort of blood donors.

Longo M, Lucci C, Marconi M, Cremonesi G Blood Transfus. 2009; 5(3):153-7.

PMID: 19204768 PMC: 2535897. DOI: 10.2450/2007.0020-07.